An Update on the Clinical Practice Guideline for Knee OA
The third edition of the American Academy of Orthopaedic Surgeons’ clinical practice guideline, Management of Osteoarthritis of the Knee (Non-Arthroplasty), has been released, and it updates 19 of the 29 evidence-based recommendations included in the previous guideline.
Consistent with the second edition, the revised guideline suggests that patients with symptomatic osteoarthritis (OA) of the knee receive 1 of the following analgesics for pain (unless there are contraindications to this treatment):
- Acetaminophen, not to exceed 3000 mg per day
- Intra-articular corticosteroids, for short-term pain relief
- Non-steroidal anti-inflammatory drugs
It does not recommend the following treatments:
- Custom made lateral wedge insoles
- Glucosamine and/or chondroitin sulfate or hydrochloride
- Needle lavage and/or debridement
“We know that treatment for osteoarthritis is not a one-size-fits-all approach, and fortunately there are a number of treatment options for orthopaedic surgeons to consider with their patients to help alleviate pain and increase mobility,” said Robert Brophy, MD, co-chair of the clinical practice guideline workgroup and member of the AAOS Committee on Evidence-Based Quality and Value.
“The updated guideline includes recommendations for patients across the spectrum of disease severity, regarding a variety of non-surgical treatments based on the current evidence. It is important for both surgeons and patients to remember that these are guiding principles, not prescriptions, on how to care for symptomatic knee osteoarthritis.”
The full clinical practice guideline on Management of Osteoarthritis of the Knee (Non-Arthroplasty) is available here.